These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9890944)
1. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. Kuhmann SE; Platt EJ; Kozak SL; Kabat D J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222 [TBL] [Abstract][Full Text] [Related]
3. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region. Platt EJ; Kuhmann SE; Rose PP; Kabat D J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617 [TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. Lee B; Sharron M; Blanpain C; Doranz BJ; Vakili J; Setoh P; Berg E; Liu G; Guy HR; Durell SR; Parmentier M; Chang CN; Price K; Tsang M; Doms RW J Biol Chem; 1999 Apr; 274(14):9617-26. PubMed ID: 10092648 [TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311 [TBL] [Abstract][Full Text] [Related]
6. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity. Khurana S; Kennedy M; King LR; Golding H J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918 [TBL] [Abstract][Full Text] [Related]
7. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan. Platt EJ; Shea DM; Rose PP; Kabat D J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436 [TBL] [Abstract][Full Text] [Related]
8. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. Kuhmann SE; Platt EJ; Kozak SL; Kabat D J Virol; 2000 Aug; 74(15):7005-15. PubMed ID: 10888639 [TBL] [Abstract][Full Text] [Related]
9. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377 [TBL] [Abstract][Full Text] [Related]
10. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events. Doranz BJ; Baik SS; Doms RW J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353 [TBL] [Abstract][Full Text] [Related]
11. HIV and SIV gp120 binding does not predict coreceptor function. Baik SS; Doms RW; Doranz BJ Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded. Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121 [TBL] [Abstract][Full Text] [Related]
13. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1. Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408 [TBL] [Abstract][Full Text] [Related]
14. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073 [TBL] [Abstract][Full Text] [Related]
15. Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution. Kuhmann SE; Madani N; Diop OM; Platt EJ; Morvan J; Müller-Trutwin MC; Barré-Sinoussi F; Kabat D J Virol; 2001 Sep; 75(18):8449-60. PubMed ID: 11507190 [TBL] [Abstract][Full Text] [Related]
16. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939 [TBL] [Abstract][Full Text] [Related]
17. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. Pontow S; Ratner L J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120. Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806 [TBL] [Abstract][Full Text] [Related]
19. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage. Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187 [TBL] [Abstract][Full Text] [Related]
20. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. Dragic T; Trkola A; Lin SW; Nagashima KA; Kajumo F; Zhao L; Olson WC; Wu L; Mackay CR; Allaway GP; Sakmar TP; Moore JP; Maddon PJ J Virol; 1998 Jan; 72(1):279-85. PubMed ID: 9420225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]